Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement
ClinicalTrials.gov study NCT05926427. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01724294. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Comb
ClinicalTrials.gov study NCT01209130. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Novel Autologou CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT03258047. IPD Sharing: YES. Countries: 1. Publications: 0.
EBV-associated Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT03378947. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)
ClinicalTrials.gov study NCT02287649. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03719560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT05296161. IPD Sharing: YES. Countries: 1. Publications: 0.
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04323956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)
ClinicalTrials.gov study NCT02060656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
ClinicalTrials.gov study NCT04798651. IPD Sharing: NO. Countries: 1. Publications: 0.
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT04007029. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Mivavotinib (CB-659) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT05319028. IPD Sharing: Not stated. Countries: 1. Publications: 0.
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT04782193. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma
ClinicalTrials.gov study NCT04993690. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19/CD20 Dual-CAR-T in B-cell Non-Hodgkin's Lymphoma Patients.
ClinicalTrials.gov study NCT04697290. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Observational Study of Diffuse Large-cell B Lymphoma
ClinicalTrials.gov study NCT06241729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02168907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
ClinicalTrials.gov study NCT03206671. IPD Sharing: NO. Countries: 8. Publications: 0.
4SCAR19U T Cells Targeting B Cell Malignancies
ClinicalTrials.gov study NCT05995015. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.